BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 4, 2005
View Archived Issues
BRL-52537, a kappa opioid receptor agonist, provides ischemic neuroprotection in males only
Read More
PARP inhibitor shows neuroprotective effects in preclinical models of ischemia
Read More
Novel ependymin-like peptides are neuroprotective in preclinical stroke model
Read More
Pfizer inlicenses Schering's ADP receptor antagonist program
Read More
Nascobal Nasal Spray receives FDA approval
Read More
Pfizer refutes Public Citizen claims on Celebrex study
Read More
IND granted for ALS-357
Read More
PT-523 studied for NSCLC in phase I/II trial
Read More
Phase II study of REN-1654 for postherpetic neuralgia completes recruitment
Read More
Safety milestone met in phase I/II bone grafting study of Tissue Repair Cells
Read More
GTx initiates phase I trial for ostarine
Read More
ODAC to review Combidex regulatory filing in March
Read More
ComGenex transfers to Echelon rights to PI3K inhibitors from joint program
Read More
Valeant to acquire Xcel Pharmaceuticals
Read More
Curis to codevelop basal cell carcinoma drug candidate with Genentech
Read More
Schwarz resubmits NDA for rotigotine
Read More
Phase III confirmatory study of Photrex planned
Read More
NovoLog Mix 70/30 reported effective as initiating insulin therapy for type 2 diabetes
Read More
Preclinical evidence for the potential benefits of sildenafil in cystic fibrosis
Read More
KRP-203 increases allograft survival in rat models of chronic rejection
Read More
Pegasys receives European approval for HIV-HCV coinfected patients
Read More
Low adiponectin levels increase the risk of CAD in type 1 diabetes
Read More
RXR-selective agonist 9c-UAB-30 prevents breast cancer without any toxicity
Read More
Pokemon: a potential new target for development of anticancer drugs
Read More
Schering claims use of Rho-kinase inhibitors for cardiac hypertrophy and aneurysm
Read More
New varenicline formulations for smoking cessation reported by Pfizer
Read More
Ranbaxy prepares novel formulations of antibiotic cefpodoxime with improved bioavailability
Read More
Novel ACE inhibitors emerge from NicOx R&D
Read More
HER2 inhibitors developed at Pfizer
Read More
HMG-CoA reductase inhibitors identified by Ranbaxy team
Read More